Sugimoto M, Sugiyama S, Yanagita N, Ozawa T
Department of Otorhinolaryngology, Faculty of Medicine, University of Nagoya, Japan.
Clin Exp Allergy. 1994 Apr;24(4):324-9. doi: 10.1111/j.1365-2222.1994.tb00242.x.
This study was designed to analyse prostaglandins (PGs) in human nasal lavage fluid using the combination of microcolumn high performance liquid chromatography and a He/Cd laser induced fluorescence detection system. Forty-seven patients with allergic rhinitis and 12 healthy volunteers were investigated. Four species of PG, i.e. PGD2, PGE2, PGF2 alpha, and 6-keto-PGF1 alpha were detected in the nasal lavage fluid. Concentrations of PGD2 (1.33 +/- 0.17 nmol/ml) and PGE2 (0.87 +/- 0.11 nmol/ml) in nasal lavage fluid from patients with allergic rhinitis (the allergy group) were significantly increased compared with those of volunteers (the control group, 0.23 +/- 0.16 nmol/ml, 0.29 +/- 0.19 nmol/ml, respectively). On the other hand, no significant differences were observed in concentrations of either PGF2 alpha or 6-keto-PGF1 alpha between the control group and the allergy group. Histamine concentration in nasal lavage fluid was significantly increased in the allergy group (53 +/- 7.6 nmol/l) compared with the control group (3.4 +/- 1.0 nmol/l). No significant correlation was observed between PGD2 and histamine concentration (r = 0.24), or between PGE2 and histamine concentration (r = 0.08) in nasal lavage fluid from patients with allergic rhinitis. Treatment with oxatomide, an anti-histamine and anti-allergic drug, significantly improved symptom scores, but did not alleviate them completely. Concentrations of each PG detected in nasal lavage fluid did not change significantly after oxatomide treatment. It is concluded that, not only histamine but also PGs, particularly PGD2 and PGE2, might be involved in the genesis of allergic rhinitis.
本研究旨在采用微柱高效液相色谱法与氦/镉激光诱导荧光检测系统相结合的方法,分析人鼻灌洗液中的前列腺素(PGs)。对47例变应性鼻炎患者和12名健康志愿者进行了研究。在鼻灌洗液中检测到4种PG,即前列腺素D2(PGD2)、前列腺素E2(PGE2)、前列腺素F2α(PGF2α)和6-酮-前列腺素F1α(6-keto-PGF1α)。变应性鼻炎患者(过敏组)鼻灌洗液中PGD2(1.33±0.17 nmol/ml)和PGE2(0.87±0.11 nmol/ml)的浓度与志愿者(对照组,分别为0.23±0.16 nmol/ml和0.29±0.19 nmol/ml)相比显著升高。另一方面,对照组和过敏组之间PGF2α或6-keto-PGF1α的浓度未观察到显著差异。与对照组(3.4±1.0 nmol/l)相比,过敏组鼻灌洗液中的组胺浓度显著升高(53±7.6 nmol/l)。变应性鼻炎患者鼻灌洗液中PGD2与组胺浓度(r = 0.24)或PGE2与组胺浓度(r = 0.08)之间未观察到显著相关性。用抗组胺和抗过敏药物奥沙米特治疗可显著改善症状评分,但不能完全缓解症状。奥沙米特治疗后,鼻灌洗液中检测到的每种PG的浓度均无显著变化。结论是,不仅组胺,而且PGs,特别是PGD2和PGE2,可能参与变应性鼻炎的发病机制。